UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential

Clinical cancer research, 2013-03, Vol.19 (5), p.961-968

2013

Volltextzugriff (PDF)

Ovarian cancer: strategies for overcoming resistance to chemotherapy

Nature reviews. Cancer, 2003-07, Vol.3 (7), p.502-516

2003

Volltextzugriff (PDF)

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research

Nature reviews. Cancer, 2013-04, Vol.13 (4), p.273-282

2013

Volltextzugriff (PDF)

MMWR Supplement on National HIV Behavioral Surveillance Among Transgender Women—Seven Urban Areas, United States, 2019-2020

Public health reports (1974), 2024-05, Vol.139 (3), p.269-270

2024

Volltextzugriff (PDF)

Mitochondrial Nitroreductase Activity Enables Selective Imaging and Therapeutic Targeting

Journal of the American Chemical Society, 2016-09, Vol.138 (37), p.12009-12012

2016

Volltextzugriff (PDF)

Beyond chemotherapy: targeted therapies in ovarian cancer

Nature reviews. Cancer, 2009-03, Vol.9 (3), p.167-181

2009

Volltextzugriff (PDF)

Binocular visual field in adults with horizontal strabismus and driving requirements

Eye (London), 2023-08, Vol.37 (11), p.2220-2225

2023

Volltextzugriff (PDF)

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2016-03, Vol.387 (10023), p.1066-1074

2016

Volltextzugriff (PDF)

Rethinking ovarian cancer: recommendations for improving outcomes

Nature reviews. Cancer, 2011-10, Vol.11 (10), p.719-725

2011

Volltextzugriff (PDF)

Average paraxial power of a lens and visual acuity

Scientific reports, 2023-05, Vol.13 (1), p.7118-7118, Article 7118

2023

Volltextzugriff (PDF)

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Journal of clinical oncology, 2012-02, Vol.30 (4), p.372-379

2012

Volltextzugriff (PDF)

Emerging therapeutic targets in endometrial cancer

Nature reviews. Clinical oncology, 2011-05, Vol.8 (5), p.261-271

2011

Volltextzugriff (PDF)

Time to replace the spherical equivalent with the average paraxial lens power

BMJ open ophthalmology, 2023-06, Vol.8 (1), p.e001340

Kaye, Stephen B

2023

Volltextzugriff (PDF)

Publisher Correction: Average paraxial power of a lens and visual acuity

Scientific reports, 2023-06, Vol.13 (1), p.9265-9265, Article 9265

2023

Volltextzugriff (PDF)

Development of Student Survey on Writing Nursing Care Plan: An exploratory sequential mixed‐methods study

Journal of nursing management, 2022-07, Vol.30 (5), p.O23-O36

2022

Volltextzugriff (PDF)

Epithelial Cell-Derived Extracellular Vesicles Trigger the Differentiation of Two Epithelial Cell Lines

International journal of molecular sciences, 2022-02, Vol.23 (3), p.1718

2022

Volltextzugriff (PDF)

Phase III Randomized Trial of Docetaxel–Carboplatin Versus Paclitaxel–Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

JNCI : Journal of the National Cancer Institute, 2004-11, Vol.96 (22), p.1682-1691

2004

Volltextzugriff (PDF)

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2512-2519

2010

Volltextzugriff (PDF)

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5530-5536

2008

Volltextzugriff (PDF)

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3107-3114

2010

Volltextzugriff (PDF)

Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3742-3748

2009

Volltextzugriff (PDF)

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Journal of clinical oncology, 2008-10, Vol.26 (28), p.4563-4571

2008

Volltextzugriff (PDF)

Warfarin Pharmacogenomics in Diverse Populations

Pharmacotherapy, 2017-09, Vol.37 (9), p.1150-1163

2017

Volltextzugriff (PDF)

Mechanisms of transcoelomic metastasis in ovarian cancer

The lancet oncology, 2006-11, Vol.7 (11), p.925-934

2006

Volltextzugriff (PDF)

1 – 25 von 4.628

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.996)
Mit Volltextzugriff
(3.539)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential

Ovarian cancer: strategies for overcoming resistance to chemotherapy

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research

MMWR Supplement on National HIV Behavioral Surveillance Among Transgender Women—Seven Urban Areas, United States, 2019-2020

Mitochondrial Nitroreductase Activity Enables Selective Imaging and Therapeutic Targeting

Beyond chemotherapy: targeted therapies in ovarian cancer

Binocular visual field in adults with horizontal strabismus and driving requirements

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Rethinking ovarian cancer: recommendations for improving outcomes

Average paraxial power of a lens and visual acuity

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Emerging therapeutic targets in endometrial cancer

Time to replace the spherical equivalent with the average paraxial lens power

Publisher Correction: Average paraxial power of a lens and visual acuity

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Development of Student Survey on Writing Nursing Care Plan: An exploratory sequential mixed‐methods study

Epithelial Cell-Derived Extracellular Vesicles Trigger the Differentiation of Two Epithelial Cell Lines

Phase III Randomized Trial of Docetaxel–Carboplatin Versus Paclitaxel–Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Warfarin Pharmacogenomics in Diverse Populations

Mechanisms of transcoelomic metastasis in ovarian cancer

Suchergebnisse filtern